Georg Stöckl

766 total citations
17 papers, 579 citations indexed

About

Georg Stöckl is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Georg Stöckl has authored 17 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 2 papers in Pulmonary and Respiratory Medicine and 1 paper in Molecular Biology. Recurrent topics in Georg Stöckl's work include Heart rate and cardiovascular health (13 papers), Cardiovascular Issues in Pregnancy (5 papers) and Heart Failure Treatment and Management (4 papers). Georg Stöckl is often cited by papers focused on Heart rate and cardiovascular health (13 papers), Cardiovascular Issues in Pregnancy (5 papers) and Heart Failure Treatment and Management (4 papers). Georg Stöckl collaborates with scholars based in Germany, United States and Poland. Georg Stöckl's co-authors include Franz Hofmann, Juliane Stieber, Stefan Herrmann, A. Ludwig, Christian Zugck, Ursula Müller‐Werdan, Karl Werdan, Sabine Kloth, Rolf Dermietzel and Henning Ebelt and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Molecular Pharmacology.

In The Last Decade

Georg Stöckl

16 papers receiving 568 citations

Peers

Georg Stöckl
Comparison fields: 5 of 82
  • Cardiology and Cardiovascular Medicine 381
  • Molecular Biology 264
  • Cellular and Molecular Neuroscience 153
  • Physiology 35
  • Surgery 30
Claudia Seyler Germany
Åsmund T. Røe Norway
K. Censier Switzerland
Stanislav Berjukow Austria
Kristina Rysevaitė Lithuania
Karin Nunley United States
Yevgeniya Lukyanenko United States
G. Küther Germany
Kenneth S. Gresham United States
Ghayath Baroudi Canada
Claudia Seyler Germany View profile →
Citations per field, relative to Georg Stöckl
Georg Stöckl · 1×
Citations per year, relative to Georg Stöckl
Georg Stöckl · 1×

Countries citing papers authored by Georg Stöckl

Since Specialization
Citations

This map shows the geographic impact of Georg Stöckl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Stöckl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Stöckl more than expected).

Fields of papers citing papers by Georg Stöckl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georg Stöckl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Stöckl. The network helps show where Georg Stöckl may publish in the future.

Co-authorship network of co-authors of Georg Stöckl

This figure shows the co-authorship network connecting the top 25 collaborators of Georg Stöckl. A scholar is included among the top collaborators of Georg Stöckl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georg Stöckl. Georg Stöckl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
# Title Journal Authors Indexed citations
1 Effectiveness and Impact on Adherence of a New Fixed-Dose Combination of Ivabradine and Metoprolol in a Wide Range of Stable Angina Patients in Real-Life Practice Cardiology and Therapy Dimitar Divchev, Georg Stöckl et al. 4
2 Treatment of Stable Angina with a New Fixed-Dose Combination of Ivabradine and Metoprolol: Effectiveness and Tolerability in Routine Clinical Practice Cardiology and Therapy Dimitar Divchev, Georg Stöckl et al. 6
3 Long-term treatment with ivabradine over 12 months in patients with chronic heart failure in clinical practice: Effect on symptoms, quality of life and hospitalizations International Journal of Cardiology Christian Zugck, Stefan Störk et al. 11
4 Effectiveness of Ivabradine Treatment in Different Subpopulations with Stable Angina in Clinical Practice: A Pooled Analysis of Observational Studies Cardiology Karl Werdan, Stefan Perings et al. 12
5 Advances in the management of heart failure: the role of ivabradine Vascular Health and Risk Management Ursula Müller‐Werdan, Georg Stöckl et al. 18
6 Effectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice Advances in Therapy Stefan Perings, Georg Stöckl et al. 7
7 Ivabradine in Combination with Beta-Blockers in Patients with Chronic Stable Angina After Percutaneous Coronary Intervention Advances in Therapy Karl Werdan, Henning Ebelt et al. 12
8 Ivabradine in Combination with Metoprolol Improves Symptoms and Quality of Life in Patients with Stable Angina Pectoris: A post hoc Analysis from the ADDITIONS Trial Cardiology Karl Werdan, Henning Ebelt et al. 13
9 Ist die Herzfrequenz bei Herzinsuffizienz-Patienten in Deutschland ausreichend kontrolliert? DMW - Deutsche Medizinische Wochenschrift Christian Zugck, Georg Stöckl et al. 5
10 Ivabradine Treatment in a Chronic Heart Failure Patient Cohort: Symptom Reduction and Improvement in Quality of Life in Clinical Practice Advances in Therapy Christian Zugck, Georg Stöckl et al. 32
11 Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: Age-related results from the ADDITIONS study Experimental Gerontology Ursula Müller‐Werdan, Georg Stöckl et al. 14
12 Flottenversuch Elektromobilität, Netzmanagementstrategien mittels elektrischer Fahrzeugflotten RWTH Publications (RWTH Aachen) Georg Stöckl, Armin Schnettler et al. 1
13 HCN4 provides a ‘depolarization reserve’ and is not required for heart rate acceleration in mice The EMBO Journal Stefan Herrmann, Juliane Stieber et al. 182
14 Functional Expression of the Human HCN3 Channel Journal of Biological Chemistry Juliane Stieber, Georg Stöckl et al. 117
15 Bradycardic and Proarrhythmic Properties of Sinus Node Inhibitors Molecular Pharmacology Juliane Stieber, Georg Stöckl et al. 97
16 Construction of an apparatus for perfusion cell cultures which enables in vitro experiments under organotypic conditions. PubMed Georg Stöckl, Sabine Kloth et al. 47
17 [Metastatic calcinosis or calciphylaxis--a case with a severe vascular calcification during intermittent hemodialysis]. PubMed H Pogglitsch, Georg Stöckl et al. 1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026